PARLIAMENTARY WRITTEN QUESTION
Pharmaceutical Price Regulation Scheme (27 May 2015)

To ask the Secretary of State for Health, in what ways the rebate from the Pharmaceutical Price Regulation Scheme has been spent in England; and if he will make it his policy that any future rebate will be allocated for treatments for (a) cystic fibrosis and (b) other long term conditions.

Asked by:
Kerry McCarthy (Labour)

Pharmaceutical Price Regulation Scheme (PPRS) payments for England all go back into spending on improving patients’ health and care. The Department includes the expected PPRS payments in setting the NHS England allocations in advance of each year.

Decisions on how NHS England medicines budgets are spent are taken by NHS England clinical leadership on the basis of clinical priorities.

Answered by:
George Freeman (Conservative)
1 June 2015